专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2005075467A2 CRYSTALLINE FORMS OF ZOLMITRIPTAN 审中-公开
标题翻译： ZOLMITRIPTAN的晶体形式
公开(公告)号：WO2005075467A2
公开(公告)日：2005-08-18
申请号：PCT/EP2005050362
申请日：2005-01-28
申请人： CIBA SC HOLDING AG , VAN DER SCHAAF PAUL ADRIAAN , BLATTER FRITZ , SZELAGIEWICZ MARTIN , BERENS ULRICH , DE PAUL SUSAN
发明人： VAN DER SCHAAF PAUL ADRIAAN , BLATTER FRITZ , SZELAGIEWICZ MARTIN , BERENS ULRICH , DE PAUL SUSAN
IPC分类号： A61K31/422 , C07D413/06 , C07D413/00
CPC分类号： C07D413/06
摘要： The present invention is directed to a novel crystalline form of Zolmitriptan, herein designated as Form A, and several novel solvates of Zolmitriptan, herein designated as Form B, C, D, E, F, and G, processes for the preparation thereof and pharmaceutical compositions comprising these crystalline forms.
摘要翻译：本发明涉及Zolmitriptan的新型结晶形式，本文命名为A型，以及佐米曲坦的几种新型溶剂合物，本文命名为B型，C，D，E，F和G型，其制备方法和药物包含这些结晶形式的组合物。

2. 发明专利

CZ20032019A3 Atorvastatin crystalline forms 未知
公开(公告)号：CZ20032019A3
公开(公告)日：2003-10-15
申请号：CZ20032019
申请日：2001-12-19
申请人： CIBA SC HOLDING AG
发明人： VAN DER SCHAAF PAUL ADRIAAN , BLATTER FRITZ , SZELAGIEWICZ MARTIN , SHONING KAI-UWE
IPC分类号： A61K31/40 , A61P3/06 , A61P43/00 , C07D207/34
摘要： The present invention is directed to new crystalline forms of Atorvastatin calcium (2:1), referred to hereinafter as polymorphic Forms X, A, B, B2, C, D and E. Furthermore, the present invention is directed to processes for the preparation of these crystalline forms and pharmaceutical compositions comprising the crystalline forms.

3. 发明专利

NO20032758L 未知
公开(公告)号：NO20032758L
公开(公告)日：2003-06-17
申请号：NO20032758
申请日：2003-06-17
申请人： CIBA SC HOLDING AG
发明人： SCHAAF PAUL ADRIAAN VAN DER , BLATTER FRITZ , SZELAGIEWICZ MARTIN , SCHOENING KAI-UWE
IPC分类号： A61K31/40 , A61P3/06 , A61P43/00 , C07D207/34
摘要： The present invention is directed to new crystalline forms of Atorvastatin calcium (2:1), referred to hereinafter as polymorphic Forms X, A, B, B2, C, D and E. Furthermore, the present invention is directed to processes for the preparation of these crystalline forms and pharmaceutical compositions comprising the crystalline forms.

4. 发明专利

AU1917502A Crystalline forms of cerivastatin sodium 未知
公开(公告)号：AU1917502A
公开(公告)日：2002-07-01
申请号：AU1917502
申请日：2001-12-12
申请人： CIBA SC HOLDING AG
发明人： SCHAAF PAUL ADRIAAN VAN DER , BLATTER FRITZ , SZELAGIEWICZ MARTIN , END NICOLE
IPC分类号： A61K31/44 , A61P3/06 , A61P9/10 , C07D213/55

5. 发明专利

NZ527048A Crystalline forms of atorvastatin 未知
公开(公告)号：NZ527048A
公开(公告)日：2004-12-24
申请号：NZ52704801
申请日：2001-12-19
申请人： CIBA SC HOLDING AG
发明人： VAN DER SCHAAF PAUL ADRIAAN , BLATTER FRITZ , SZELAGIEWICZ MARTIN , SCHONING KAI-UWE
IPC分类号： A61K31/40 , A61P3/06 , A61P43/00 , C07D207/34
摘要： A crystalline polymorph of [R-(R*,R*)]-2-(4-fluorophenyl)-b,d-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (atorvastatin calcium) exhibits a characteristic X-ray powder diffraction pattern with characteristic peaks expressed in d-values (A) at a) 27.9 (s), 20.9 (w), 18.9 (w), 16.1 (w), 11.1 (m), 10.5 (m), 9.1 (m), 5.53 (m), 5.07 (w), 4.77 (vw), 4.55 (m), 4.13 (w), 3.69 (w); b) 31.0 (vw), 18.6 (m), 17.0 (w), 15.3 (vw), 12.8 (w), 11. 2 (m), 9.6 (s), 9.3 (w), 8.6 (w), 7.4 (m), 6.5 (vw), 6. 2 (vw), 5.47 (w), 5.21 (m), 4.64 (vs), 4.46 (s), 4.14 (m), 3.97 (m), 3.74 (m), 3.62 (vw), 3.38 (w), 3.10 (m); c) 27.9 (m), 17.0 (m), 14.2 (w), 12.1 (vs), 10.1 (s), 8.6 (m), 7.1 (m), 6.1 (vw), 5.27 (m), 4.89 (m), 4.68 (m), 4.46 (m), 4.22 (m), 3.90 (w), 3.70 (w), 2.36 (vw); d) 28.1 (m), 17.2 (m), 14.0 (vw), 12.3 (s), 10.4(s), 8.6 (m), 7.5 (w), 7.0 (m), 5.28 (m), 4.88 (m), 4.55 (m), 4.27 (m), 3.88 (vw), 3.73 (m); e) 28.8 (m), 24.0 (m), 17.1 (m), 11.3 (s), 9.8 (vw), 8.3 (w), 7.7 (vw), 6.9 (vw), 5.64 (vw), 5.21 (w), 4.59 (m), 4.39 (w), 4.16 (w), 3.70 (w); f) 33.7 (w), 31.0 (m), 16.9 (m), 10.3 (s), 7.7 (w), 6.4 (vw), 4.84 (s) and g) 26.8 (s), 9.4 (w), 4.6 (m) wherein (s) = strong intensity; (m) = medium intensity; (w) = weak intensity. Atorvastatin calcium is an orally-active hypocholesterolaemic, a liver-selectiveHMG-CoA reductase inhibitor.

6. 发明专利

NO20032758A 未知
公开(公告)号：NO20032758A
公开(公告)日：2003-06-17
申请号：NO20032758
申请日：2003-06-17
申请人： CIBA SC HOLDING AG
发明人： SCHAAF PAUL ADRIAAN VAN DER , BLATTER FRITZ , SZELAGIEWICZ MARTIN , SCHOENING KAI-UWE
IPC分类号： A61K31/40 , A61P3/06 , A61P43/00 , C07D207/34
CPC分类号： C07D207/34

7. 发明专利

CA2594692A1 CRYSTALLINE FORMS OF ROSUVASTATIN CALCIUM SALT 未知
公开(公告)号：CA2594692A1
公开(公告)日：2006-08-03
申请号：CA2594692
申请日：2006-01-23
申请人： CIBA SC HOLDING AG
发明人： VAN DER SCHAAF PAUL ADRIAAN , SZELAGIEWICZ MARTIN , BLATTER FRITZ
IPC分类号： C07D239/42 , A61K31/505 , A61P3/06
摘要： Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid] (also known as rosuvastatin) calcium salt and hydrates can exist in new crystal forms B and C. These crystal forms provide a higher diversity on crystalline materials to optimize manufacture, formulation and biological efficiency.

8. 发明专利

PL376557A1 Postacie krystaliczne pitawastatyny wapnia 未知
公开(公告)号：PL376557A1
公开(公告)日：2006-01-09
申请号：PL37655704
申请日：2004-02-02
申请人： CIBA SC HOLDING AG
发明人： VAN DER SCHAAF PAUL ADRIAAN , BLATTER FRITZ , SZELAGIEWICZ MARTIN , SCHOENING KAI-UWE
IPC分类号： C07D215/14 , A61K31/47 , A61P9/00

9. 发明专利

AU2004212160A1 Crystalline forms of pitavastatin calcium 未知
公开(公告)号：AU2004212160A1
公开(公告)日：2004-08-26
申请号：AU2004212160
申请日：2004-02-02
申请人： CIBA SC HOLDING AG
发明人： BLATTER FRITZ , SZELAGIEWICZ MARTIN , SCHONING KAI-UWE , SCHAAF PAUL ADRIAAN VAN DER
IPC分类号： A61K31/47 , A61P9/00 , C07D215/14
摘要： The present invention is directed to new crystalline forms of Pitavastatin hemicalcium salt, referred to hereinafter as polymorphic Forms A, B, C, D, E and F, as well as the amorphous form. Furthermore, the present invention is directed to processes for the preparation of these crystalline forms and the amorphous form and pharmaceutical compositions comprising these crystalline forms or the amorphous form.

10. 发明专利

SK9532003A3 Crystalline forms of atorvastatin calcium 未知
公开(公告)号：SK9532003A3
公开(公告)日：2004-04-06
申请号：SK9532003
申请日：2001-12-19
申请人： CIBA SC HOLDING AG
发明人： VAN DER SCHAAF PAUL ADRIAAN , BLATTER FRITZ , SZELAGIEWICZ MARTIN , SCHONING KAI-UWE
IPC分类号： A61K31/40 , A61P3/06 , A61P43/00 , C07D207/34
摘要： The present invention is directed to new crystalline forms of Atorvastatin calcium (2:1), referred to hereinafter as polymorphic Forms X, A, B, B2, C, D and E. Furthermore, the present invention is directed to processes for the preparation of these crystalline forms and pharmaceutical compositions comprising the crystalline forms.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式